NxStage Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 84   

Articles published

NXTM 17.03 +0.19 (1.13%)
price chart
NxStage Medical to Present Positive Data on System One
Massachusetts-based manufacturer of innovative dialysis products, NxStage Medical, Inc. (NXTM - Snapshot Report), will present four new abstracts demonstrating clinical results during the National Kidney Foundation's Spring Clinical Meeting in Dallas, TX.
Zacks: Analysts Give $20.75 Consensus Target Price to NxStage Medical ...  sleekmoney
New Data Show Improved Survival, Reduced Cardiovascular Hospital ...  MarketWatch
Why NxStage Medical Inc. Stock Surged Higher
This article originally appeared as part of ongoing coverage in our premium Motley Fool Rule Breakers service... we hope you enjoy this complimentary peek!
Why Are Traders Paying Attention To Uranium Energy Corp.(NYSEMKT:UEC ...  Scibility Media
Related articles »  
Canaccord Genuity Analyst Recommendation Update on NxStage Medical, Inc.
Canaccord Genuity maintains its view on NxStage Medical, Inc. (NASDAQ:NXTM) according to the research report released by the firm to its investors.
Analyst Rating Update on NxStage Medical, Inc.  Bar and Graph Report
NxStage Medical Receives Consensus Recommendation of �Buy� from Analysts ...  Dakota Financial News
NxStage Medical (NXTM) Q4 Loss Narrower than Expected
Manufacturer of innovative dialysis products, NxStage Medical Inc. (NXTM - Snapshot Report), reported adjusted loss of 8 cents per share in the fourth quarter of 2014, narrower than the Zacks Consensus Estimate of loss by a couple of cents.
NxStage Medical Inc. (NXTM) is Trading Higher on Unusual Volume for March 05  Equities.com
NxStage Medical Inc. (NXTM) is Trading Lower on Unusual Volume for March 10
NxStage Medical Inc. ($NXTM) experienced unusually high volume on Mar. 10, as the stock lost 1.92% to a closing price of $16.32.
First Call Rating Update on NxStage Medical, Inc.  Bar and Graph Report
Why NxStage Medical Inc. Shares Slumped
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Related articles »  
NxStage Medical Inc. (NXTM) is Trading Higher on Unusual Volume for February ...
NxStage Medical Inc. ($NXTM) experienced unusually high volume on Feb. 26, as the stock gained 0.17% to a closing price of $18.11.
NxStage Medical Inc. (NXTM) is Trading Lower on Unusual Volume for February ...
NxStage Medical Inc. ($NXTM) experienced unusually high volume on Feb. 27, as the stock lost 5.14% to a closing price of $17.18.
Brokerages Give Consensus Recommendation of "Buy" to NxStage Medical ...
Brokers have set a twelve-month consensus target price of $20.75 for the company and are forecasting that the company will post ($0.11) EPS for the current quarter, according to Zacks. Zacks has also assigned NxStage Medical an industry rank of 108 out ...
NxStage Medical CEO Sells $348000.00 in Stock (NXTM)  Mideast Time
Form 4 NxStage Medical, Inc. For: Mar 03 Filed by: Turk Joseph E Jr
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). 1. Name and Address of Reporting Person *. Turk Joseph E Jr. (Last), (First), (Middle). 350 MERRIMACK STREET. (Street). LAWRENCE, MA ...